Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II.

Preskorn, Sheldon H

Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II. [electronic resource] - Journal of psychiatric practice Sep 2006 - 312-6 p. digital

Publication Type: Journal Article; Review

1527-4160

10.1097/00131746-200609000-00006 doi


Anti-HIV Agents--adverse effects
Antidepressive Agents--adverse effects
Antiparkinson Agents--adverse effects
Apomorphine--adverse effects
Atazanavir Sulfate
Azabicyclo Compounds
Carbamates--therapeutic use
Central Nervous System Agents--adverse effects
Cytochrome P-450 Enzyme System--metabolism
Drug Approval--legislation & jurisprudence
Drug Interactions
Duloxetine Hydrochloride
Furans
Humans
Hypnotics and Sedatives--adverse effects
Indenes--adverse effects
Long QT Syndrome--chemically induced
Mental Disorders--drug therapy
Oligopeptides--adverse effects
Organophosphates--therapeutic use
Piperazines--adverse effects
Psychopharmacology--methods
Pyridines--adverse effects
Sulfonamides--therapeutic use
Thiophenes--adverse effects